Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)

SHA:603858 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	17,769	16,838	18,814	23,238	23,326	25,516
Market Cap Growth	6.07%	-10.50%	-19.04%	-0.38%	-8.58%	11.88%
Enterprise Value	19,539	19,100	21,044	23,744	25,505	27,096
Last Close Price	16.85	15.47	16.52	19.41	19.11	20.36
PE Ratio	10687.88	-	58.98	-	18.09	13.71
Forward PE	-	25.13	25.13	25.13	25.13	25.13
PS Ratio	1.62	1.53	1.42	1.55	1.48	1.59
PB Ratio	1.76	1.72	1.65	1.89	1.61	1.85
P/TBV Ratio	1.95	1.92	2.05	2.52	2.87	3.47
P/FCF Ratio	18.51	22.66	-	10.50	26.30	17.94
P/OCF Ratio	16.87	17.91	-	8.43	17.67	13.03
EV/Sales Ratio	1.78	1.74	1.59	1.59	1.62	1.69
EV/EBITDA Ratio	13.55	17.12	13.06	10.53	11.42	9.99
EV/EBIT Ratio	17.80	28.06	20.32	13.37	14.65	11.85
EV/FCF Ratio	20.36	25.71	-	10.73	28.76	19.05
Debt / Equity Ratio	0.38	0.38	0.29	0.27	0.25	0.25
Debt / EBITDA Ratio	2.66	3.29	2.02	1.45	1.57	1.27
Debt / FCF Ratio	4.00	5.00	-	1.49	3.99	2.43
Asset Turnover	0.55	0.55	0.62	0.65	0.67	0.73
Inventory Turnover	0.91	0.95	0.99	1.12	1.25	1.59
Quick Ratio	0.44	0.37	0.45	0.71	0.57	0.62
Current Ratio	1.15	1.06	1.21	1.29	1.17	1.02
Return on Equity (ROE)	-1.24%	-6.63%	1.28%	-11.91%	8.74%	13.36%
Return on Assets (ROA)	3.45%	2.12%	3.02%	4.83%	4.64%	6.49%
Return on Invested Capital (ROIC)	-7.54%	5.25%	3.03%	12.26%	7.92%	12.03%
Return on Capital Employed (ROCE)	8.70%	5.60%	7.40%	11.80%	10.30%	15.20%
Earnings Yield	0.01%	-3.29%	1.70%	-6.58%	5.53%	7.29%
FCF Yield	5.40%	4.41%	-3.86%	9.52%	3.80%	5.57%
Dividend Yield	4.59%	-	0.76%	4.95%	1.88%	2.58%
Payout Ratio	31925.73%	-	374.41%	-	57.88%	133.71%
Buyback Yield / Dilution	3.15%	2.01%	0.00%	0.01%	-0.01%	0.87%
Total Shareholder Return	7.73%	2.01%	0.76%	4.95%	1.88%	3.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.